+91-9666438880
indiaord@gmail.com
IORD – Indian Organization for Rare DiseasesIORD – Indian Organization for Rare DiseasesIORD – Indian Organization for Rare DiseasesIORD – Indian Organization for Rare Diseases
  • Home
  • About Us
    • Management Committee
    • Advisory Board
    • Newsletters
    • Newsletter Subscription
  • Rare Diseases
  • Research
  • Services
  • Donate
  • Gallery
    • Photo Gallery
      • World Rare Disease Day – 2023
      • World Rare Disease Day 2020
    • Video Gallery
      • World Rare Disease Day – 2020
      • World Rare Disease Day – 2019
      • World Rare Disease Day – 2018
  • Blog
  • Contact Us

Research Publication: How to Manage Rare Disease with Rashtriya Bal Swasthya Karyakram

    Home Rare Disease News Research Publication: How to Manage Rare Disease with Rashtriya Bal Swasthya Karyakram
    NextPrevious
    How Rashtriya Bal Swasthya Karyakram can be used to manage rare diseases in India

    Research Publication: How to Manage Rare Disease with Rashtriya Bal Swasthya Karyakram

    By IORD | Rare Disease News, Uncategorised | 0 comment | 24 June, 2023 | 1

    This is an excerpt from a research paper titled Expansion of India’s national child healthcare programme, Rashtriya Bal Swasthya Karyakram (RBSK), for rare Disease management: a health policy perspective. This was published in the research journal Orphanet Journal of Rare Diseases.

    The Rashtriya Bal Swasthya Karyakram (RBSK) is a government program under the National Health Mission (NHM) for school children that aims to provide comprehensive care and support for their well-being.

    Launched in 2013 under the National Health Mission, RBSK focuses on the prevention, early identification, and management of various health conditions in children from birth to 18 years of age. These conditions, categorized under 4Ds (Defects at birth, Diseases, Deficiencies, and Developmental delays including Disabilities), include rare diseases.

    RBSK utilizes community public healthcare resources to conduct screenings and relies on referrals and cross-referrals between secondary and tertiary healthcare units for efficient diagnosis and treatment management of these conditions. District Early Intervention Centers (DEIC) serve as the initial point of reference after the screening, playing a vital role in providing referrals, continuity of care, and maintaining records.

    In this study, a three-member team of researchers led by Pragya Chaube, Arun K. Singh, and Mohua Chakraborty Choudhury makes a case for using RBSK for better management, diagnosis and treatment of rare diseases in India.

    Rare Diseases: Prevalence

    Rare diseases pose a significant but relatively unknown burden in India, with an estimated 72-96 million people living with rare diseases. It is noteworthy that a significant proportion (50-75%) of rare diseases manifest in childhood and during birth. This study proposes the integration of RBSK into the rare disease management system, suggesting that RBSK can play a valuable role in addressing the needs of children with rare diseases.

    The authors of this study present these recommendations as representative of health policy researchers, emphasizing the potential benefits of incorporating RBSK into the management, diagnosis, and treatment of rare diseases in India. Here are their recommendations:

    1. Expanding the capacity of RBSK: Currently, RBSK covers thirty diseases. However, expanding its scope will allow routine screenings to identify anomalies that may indicate the presence of a rare disease (RD). These children can then be referred to tertiary care facilities and Centers of Excellence (CoEs) for specific diagnoses.
    2. Establishing an effective referral mechanism: A strategic referral system should be implemented to connect District Early Intervention Centers (DEICs) with the network of CoEs and National Inherited Disorders Administration (NIDAN) Kendras, ensuring timely diagnosis and early intervention. NIDAN Kendras, established by the Department of Biotechnology, provide clinical care, prenatal testing, newborn screening, and genetic counselling for genetic disorders. Provision for teleconsultation within RBSK should be made, particularly for cases where tertiary healthcare facilities are located far away. This would enable local healthcare providers to receive virtual assistance from CoEs.
    3. Expanding the target group through public-private partnership: According to the National Sample Survey, 61% of the urban population largely relies on private healthcare systems. Implementing RBSK guidelines through private healthcare facilities will enhance access and alleviate the burden on public healthcare systems, allowing them to focus on economically disadvantaged sections.
    4. Conducting resource mapping: Mapping resources for tertiary healthcare services related to RDs should be done at the national level, with the involvement of private partners in select areas where special provisions are needed.
    5. Generating awareness: It is crucial to raise awareness and build capacity among healthcare workers and professionals regarding RDs in India. This awareness and training should extend beyond medical professionals to the entire RBSK network, including Ayurveda, Yoga, Naturopathy, Unani, Siddha, and Homeopathy (AYUSH) doctors, Mobile Health Teams, and ASHA workers.
    6. Expanding genetic counselling services: Connecting the RBSK system and DEICs with NIDAN Kendras would facilitate the availability and accessibility of genetic services. Private genetic diagnostics services can be incorporated through Memorandums of Understanding (MoUs) with DEICs, particularly in areas where public health settings have limited genetic service capacities.
    7. Establishing a comprehensive data repository: RBSK should enable the inclusion of comprehensive family history data before diagnosis. A proper framework should be developed to integrate genetic diagnostic data within the larger data repository.
    8. Follow-up of SNCU Rare Disease children: Under the Home-Based Care for Young Children program, ASHA workers currently track and record the progress of children until 15 months of age. However, for children with RDs or those admitted to Special Newborn Care Units with a family history of RDs, this period may be extended until the age of 6, until they are enrolled in schools and included in the RBSK system.
    9. Integrating patient groups in healthcare delivery: RBSK can formally integrate patient groups into the healthcare delivery system by connecting diagnosed patients and clinicians with these groups.
    rare disease awareness, rare disease india, rare disease management in India, Rare disease treatment, Rare Diseases in India, Rashtriya Bal Swasthya Karyakram, RBSK

    IORD

    More posts by IORD

    Related Post

    • Inaugural session of World Rare Disease Day 2026 conference in Hyderabad, with experts from IORD, LVPEI, and Rainbow Children’s Hospital

      India: Rare Ophthalmic Disorders Take Centrestage at World Rare Disease Day-2026

      By IORD | 0 comment

      The event, attended by leading ophthalmologists, ocular geneticists, pediatric specialists, researchers, and patient advocates, spotlighted the urgent need for early diagnosis, stronger referral pathways, and expanded genetic and multidisciplinary services to address the growing burdenRead more

    • On World Rare Disease Day 2026, IORD, along with LV Prasad Eye Institute and Rainbow Children’s Hospital, is hosting a scientific conference in Hyderabad focused on Rare Ophthalmic Disorders

      IORD to Host World Rare Disease Day 2026 Conference Focused on Rare Ophthalmic Conditions

      By IORD | 0 comment

      Registration is now open. Limited seats available — register now using this link. Hyderabad, February 2026: The Indian Organisation for Rare Diseases (IORD), in collaboration with L V Prasad Eye Institute (LVPEI) and Rainbow Children’s Hospital,Read more

    • In this letter, IORD urges the Government of India to ensure affordable access to orphan drugs for rare disease patients through a public-interest, Section 8 non-profit pharmaceutical model supported by CSR funding.

      Bridging India’s Rare Disease Treatment Gap Through Public-Interest Pharmaceuticals

      By IORD | 0 comment

      IORD proposes a Section 8, CSR-supported public-interest pharmaceutical model to ensure affordable access to orphan drugs for millions of Indian patients.

    • IORD leaders urge inclusive, global collaboration to turn the WHA Rare Disease Resolution into real action at the RDI Asia-Pacific Webinar on October 9.

      From Hope to Action: IORD Calls for Inclusive Global Action on Rare Diseases

      By IORD | 0 comment

      The RDI Regional Webinar on “From the WHA Resolution to Action: Next Steps for Asia Pacific” marked a pivotal moment for regional cooperation on rare diseases.   “Hope” — that was the word chosen byRead more

    • Delhi High Court clears Natco to launch Risdiplam generic version Natsmart, making SMA treatment affordable for thousands of Indian families.

      Natco Wins Patent Battle, Makes SMA Drug Affordable in India

      By IORD | 0 comment

      Delhi High Court clears Natco to launch Risdiplam generic version Natsmart, making SMA treatment affordable for thousands.

    NextPrevious

    Categories

    • ABN Andhra Jyothi
    • ANI
    • Deccan Chronicle
    • Economic Times
    • Eenadu
    • Events
    • IORD in News
    • IORD Updates
    • News
    • Pharmabiz.com
    • Prime9 News
    • Rare Disease News
    • Rare Disease Survivor
    • Sakshi
    • Telangana Today
    • The Hans India
    • The Hindu
    • The Pioneer
    • Times Now
    • Times of India
    • Uncategorised
    • Vaartha

    Recent Posts

    • India: Rare Ophthalmic Disorders Take Centrestage at World Rare Disease Day-2026
    • IORD to Host World Rare Disease Day 2026 Conference Focused on Rare Ophthalmic Conditions
    • Bridging India’s Rare Disease Treatment Gap Through Public-Interest Pharmaceuticals
    • India Steps Forward as a Global Leader in Rare Disease Management
    • From Hope to Action: IORD Calls for Inclusive Global Action on Rare Diseases

    Archives

    • March 2026
    • February 2026
    • January 2026
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • September 2024
    • July 2024
    • June 2024
    • May 2024
    • March 2024
    • February 2024
    • December 2023
    • October 2023
    • July 2023
    • June 2023
    • May 2023
    • April 2023
    • March 2023
    • February 2023
    • January 2023
    • December 2022
    • November 2022
    • October 2022
    • September 2022
    • August 2022
    • June 2022
    • May 2022
    • April 2022
    • March 2022
    • February 2022
    • January 2022
    • December 2021
    • November 2021
    • October 2021
    • September 2021
    • August 2021
    • July 2021
    • May 2021
    • April 2021
    • November 2020
    • March 2020
    • February 2020
    • January 2020
    • February 2019
    • January 2018
    • September 2015

    IORD

    Indian Organization For Rare Diseases (IORD), a not-for-profit umbrella organization represents interests of all stakeholders of Rare Diseases in India including individual patients, patient support groups, health policy advocates and health care providers.

    RARE DISEASES

    • Rare Blood Diseases
    • Rare Heart Diseases
    • Rare Fungal Diseases
    • Rare Kidney Diseases
    • Rare Newborn Diseases
    • more...

    SERVICES

    • Research
    • Let's Come Together
    • Partner With Us
    • Volunteers
    • Privacy Policy
    • Sitemap

    CONTACT US

    Indian Organization For Rare Diseases
    Registered Office (India):
    Plot No. 397, Road No. 22B, Jubilee Hills, Hyderabad – 500033, Telangana, India.

    Phone: +91-9666438880

    Email: indiaord@gmail.com

    © 2020 Indian Organization For Rare Diseases | All Rights Reserved. Powered By Digital Dynamics
    • Home
    • About Us
      • Management Committee
      • Advisory Board
      • Newsletters
      • Newsletter Subscription
    • Rare Diseases
    • Research
    • Services
    • Donate
    • Gallery
      • Photo Gallery
        • World Rare Disease Day – 2023
        • World Rare Disease Day 2020
      • Video Gallery
        • World Rare Disease Day – 2020
        • World Rare Disease Day – 2019
        • World Rare Disease Day – 2018
    • Blog
    • Contact Us
    IORD – Indian Organization for Rare Diseases